Literature DB >> 19563862

The role of gut hormones in the regulation of body weight and energy homeostasis.

Efthimia Karra1, Rachel L Batterham.   

Abstract

Obesity is one of the greatest public health challenges of the 21st century with 1.6 billion adults currently classified as being overweight and 400 million as obese. Obesity is causally associated with type 2 diabetes, hypertension, cardiovascular disease, obstructive sleep apnoea and certain forms of cancer and is now one of the leading causes of mortality and morbidity worldwide. The gastrointestinal tract is the largest endocrine organ in the body producing hormones that have important sensing and signaling roles in regulating body weight and energy expenditure. The last decade has witnessed a marked increase in our understanding of the role of gut hormones in energy homeostasis. Consequently, strategies aimed at modulating circulating gut hormone concentrations or targeting their receptors are being developed as potential pharmacotherapies for obesity. This review summarizes the current knowledge regarding the mechanisms, sites of action and effects of the anorectic gut hormones peptide tyrosine-tyrosine (PYY), pancreatic polypeptide (PP), oxyntomodulin, and amylin and of the unique orexigenic hormone, ghrelin. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563862     DOI: 10.1016/j.mce.2009.06.010

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  57 in total

1.  Mesoporous silicon (PSi) for sustained peptide delivery: effect of psi microparticle surface chemistry on peptide YY3-36 release.

Authors:  Miia Kovalainen; Juha Mönkäre; Ermei Mäkilä; Jarno Salonen; Vesa-Pekka Lehto; Karl-Heinz Herzig; Kristiina Järvinen
Journal:  Pharm Res       Date:  2011-10-27       Impact factor: 4.200

Review 2.  Acute exercise and hormones related to appetite regulation: a meta-analysis.

Authors:  Matthew M Schubert; Surendran Sabapathy; Michael Leveritt; Ben Desbrow
Journal:  Sports Med       Date:  2014-03       Impact factor: 11.136

Review 3.  New targets to treat obesity and the metabolic syndrome.

Authors:  Kathleen A Martin; Mitra V Mani; Arya Mani
Journal:  Eur J Pharmacol       Date:  2015-05-19       Impact factor: 4.432

4.  Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding.

Authors:  Zehra Esra Ilhan; John K DiBaise; Nancy G Isern; David W Hoyt; Andrew K Marcus; Dae-Wook Kang; Michael D Crowell; Bruce E Rittmann; Rosa Krajmalnik-Brown
Journal:  ISME J       Date:  2017-05-26       Impact factor: 10.302

Review 5.  Bone metabolism in obesity and weight loss.

Authors:  Sue A Shapses; Deeptha Sukumar
Journal:  Annu Rev Nutr       Date:  2012-08-21       Impact factor: 11.848

6.  Deoxynivalenol (Vomitoxin)-Induced Cholecystokinin and Glucagon-Like Peptide-1 Release in the STC-1 Enteroendocrine Cell Model Is Mediated by Calcium-Sensing Receptor and Transient Receptor Potential Ankyrin-1 Channel.

Authors:  Hui-Ren Zhou; James J Pestka
Journal:  Toxicol Sci       Date:  2015-03-18       Impact factor: 4.849

Review 7.  Nutrition and L and K-enteroendocrine cells.

Authors:  Ruth Gutierrez-Aguilar; Stephen C Woods
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2011-02       Impact factor: 3.243

8.  Vagal Sensory Neuron Subtypes that Differentially Control Breathing.

Authors:  Rui B Chang; David E Strochlic; Erika K Williams; Benjamin D Umans; Stephen D Liberles
Journal:  Cell       Date:  2015-04-16       Impact factor: 41.582

Review 9.  Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Yvette Taché
Journal:  Peptides       Date:  2009-11-26       Impact factor: 3.750

Review 10.  Childhood obesity for pediatric gastroenterologists.

Authors:  Jeannie S Huang; Sarah E Barlow; Ruben E Quiros-Tejeira; Ann Scheimann; Joseph Skelton; David Suskind; Patrika Tsai; Victor Uko; Joshua P Warolin; Stavra A Xanthakos
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-01       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.